Linq heart monitor3/31/2023 Finally, the financial department was asked to provide costs of personnel, equipment, medication, disposable materials, and overhead. Cath lab managers were asked to provide details on the equipment and organization of the cath lab (cath lab occupancy, turn-around cycle, and cath lab case load). Implanters were asked to describe the patient care pathway as well as the procedure with respect to time required by members of staff and resource utilization (instruments, materials, and medication) during the time the procedure room was occupied. Data were collected from semi-structured interviews with experienced implanters (six physicians and two nurses), cath lab managers and financial departments. MethodsĪ bottom-up costing methodology was used in this cost comparison study. Hospitals can use the results of this study to estimate the change in costs from switching implant location. In this study, we compare the procedure and associated costs of inserting Reveal LINQ in a procedure room to implanting its predecessor, Reveal XT, in a cath lab or EP lab. The insertion of Reveal LINQ has been shown to be simpler and faster than the implantation of other ICMs 24 and the procedure can be moved out of the cath lab, which might result in costs savings from less staff time and lower room-related costs. 23 An alternative location could be a standard clinical examination room, where minor surgical procedures are performed (called a procedure room in this study). This means that the procedure can be moved out of the catheterization laboratory (cath lab) or electrophysiology (EP) lab to a less resource intensive setting. Owing to the miniaturization of the device and a specifically developed insertion kit, the procedure is minimally invasive. 22 The recently developed Reveal LINQ™ (Medtronic, Tolochenaz, Switzerland) is the smallest device currently available it is 88% smaller in volume than the previous ICM model Reveal ® XT. 16–21ĭifferent devices from various companies are available on the market. 14, 15 While ICMs are mostly used for the indication of syncope, some ICMs have the additional function to detect atrial fibrillation (AF) and are used in primary and secondary stroke prevention and for monitoring AF after an ablation. 13 The diagnostic yield of ICM in unexplained syncope has been shown to be between 43 and 52% while conventional tests have a diagnostic yield of 6–20%. 12 Implantable cardiac monitors have increasingly been used for the clinical evaluation of unexplained syncope in the last decade as they were shown to have a high diagnostic yield and shortened the time to diagnosis. Detection of arrhythmias, the most common cardiac causes of syncope, is important, because of the associated mortality risk. 7–11 If diagnostic testing during the syncope investigation does not result in a diagnosis, prolonged ECG monitoring is the main tool for diagnosing a cardiac cause of syncope. 1–6 The rate of patients with recurrent syncope that remains unexplained varies between 5 and 20%, the most common rate is 18%. Implantable cardiac monitors are well established in clinical guidelines and clinical practice for the diagnosis of unexplained syncope. Information is stored in its circular memory as electrocardiograms (ECGs) and can be reviewed later. Implantable cardiac monitors are widely used for detection of suspected arrhythmia. This study assesses changes in hospital practice and resource use as a result of a new miniaturized implantable cardiac monitor. Improvements in technology can change clinical practice and may lead to a more efficient use of healthcare resources. The patient care pathway is improved since waiting time for the device can be reduced as well as waiting time during the day of procedure. The procedural efficiencies and change in implant location lead to cost savings the net cost savings depend on the prices of the two devices. Owing to the miniaturized size and specifically designed insertion kit, the procedure no longer needs to take place in a cath lab, but can be performed in a less resource intensive setting. The insertion of a miniaturized cardiac monitor is simpler and faster than the implantation of the previous version. This study documents that miniaturization of technology saves hospital resources.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |